nuke
Bluelighter
- Joined
- Nov 7, 2004
- Messages
- 4,191
Treatment Study: Reducing Cocaine/Heroin Abuse With SR-Amphetamine and Buprenorphine
This research study takes place at Wayne State University and will take about 11 weeks to complete. This is a treatment research study for individuals who currently have cocaine abuse or dependence, and who may also have heroin dependence. The purpose of this study is to test whether oral sustained release d-amphetamine (SR-AMP) is safe and more effective than placebo for preventing relapse to cocaine use for individuals who abuse or are dependent upon cocaine. We are also interested whether, for patients who are dependent on cocaine and heroin, whether SR-AMP is safe and effective for preventing cocaine relapse in combination with buprenorphine.
Estimated Enrollment: 40
Study Start Date: April 2008
Estimated Study Completion Date: December 2010
Estimated Primary Completion Date: December 2010 (Final data collection date for primary outcome measure)
Contacts
Contact: Lisa Sulkowski (313) 993-3966 [email protected]
Locations
United States, Michigan
Wayne State University Recruiting
Detroit, Michigan, United States, 48202
Contact: Mark Greenwald, PhD 313-993-3965 [email protected]
Principal Investigator: Mark Greenwald, PhD
http://clinicaltrials.gov/ct2/show/NCT00698737
This research study takes place at Wayne State University and will take about 11 weeks to complete. This is a treatment research study for individuals who currently have cocaine abuse or dependence, and who may also have heroin dependence. The purpose of this study is to test whether oral sustained release d-amphetamine (SR-AMP) is safe and more effective than placebo for preventing relapse to cocaine use for individuals who abuse or are dependent upon cocaine. We are also interested whether, for patients who are dependent on cocaine and heroin, whether SR-AMP is safe and effective for preventing cocaine relapse in combination with buprenorphine.
Estimated Enrollment: 40
Study Start Date: April 2008
Estimated Study Completion Date: December 2010
Estimated Primary Completion Date: December 2010 (Final data collection date for primary outcome measure)
Contacts
Contact: Lisa Sulkowski (313) 993-3966 [email protected]
Locations
United States, Michigan
Wayne State University Recruiting
Detroit, Michigan, United States, 48202
Contact: Mark Greenwald, PhD 313-993-3965 [email protected]
Principal Investigator: Mark Greenwald, PhD
http://clinicaltrials.gov/ct2/show/NCT00698737